Skip to content

Vulnerability for new episodes in recurrent major depressive disorder: Protocol for the longitudinal DELTA-neuroimaging cohort study

· 0 citations · 208 references

TL;DR

Improved MDD-recurrence understanding is aimed at by studying these four selected perspectives in combination and prospectively during remission by studying different predictors of recurrence in combination.

View source

Similar papers

Open access Aug 2026

The timeline of brain aging in major depression: A prospective study from before first-onset to established illness

Major depressive disorder (MDD) has been associated with accelerated structural brain aging, yet whether this reflects a pre-existing neurobiological vulnerability, a dynamic acute state effect, or an accumulating biological residual remains unresolved. Across two longitudinal cohorts (N=3220), including a unique sampl...

M. Konowski, A. Kraus, J. Goltermann et al. · 0 citations
Sep 2026

Multilevel dynamic abnormalities of suicidal ideation in major depressive disorder from regional dynamics to network states.

A multi-level perspective on the dynamic neural mechanisms of suicidality is provided and regional and network-level dynamic abnormalities may differentially contribute to trait SI, recent SI, and treatment-related improvements.

Yi-Fan Jing, Lin Jing, Xiong-Ying Chen et al. · 0 citations
Open access Jul 2026

Gut Microbiome in Depression with and without REM Sleep Behavior Disorder.

Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations, and MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk.

Yuhua Yang, Ningning Li, Li Zhou et al. · 0 citations
Review Aug 2026

Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges

The neurobiological basis of cognitive impairment in MDD is explored, key biomarkers associated with these deficits are identified, and their implications for diagnosis, prognosis, and therapeutic intervention are discussed.

Akansha Thakur, Parag Jain, M. Sharma et al. · 0 citations
Open access Sep 2026

Cognitive Reserve as a Stratification Factor for Cognitive Impairment and Disease Progression in Major Depressive Disorder.

The moderating effect of CR on the brain network-cognition association provides a neurobiological rationale for this vulnerability and supports incorporating CR into routine clinical assessment to guide risk stratification and personalized treatment planning.

M. Gruber, Henrike Renaud, M. Mauritz et al. · 0 citations
Open access Aug 2026

What are the clinical implications of mixed features in major depressive disorder? A VAST-D report.

Mixed features were highly prevalent and associated with greater clinical burden, and Assessment of mixed features may provide clinically relevant information when selecting next-step pharmacologic strategies, particularly when considering a switch to bupropion sustained release.

Sidney Zisook, Lori L Davis, Trisha Suppes et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.